Kazia Therapeutics Limited American Depositary Shares (KZIA) is a publicly traded Healthcare sector company. As of November 3, 2026, KZIA trades at $8.14 with a market cap of $132.17M and a P/E ratio of 0.00. KZIA moved -5.65% today. Year to date, KZIA is +62.16%; over the trailing twelve months it is +3.82%. Its 52-week range spans $2.86 to $17.40. Analyst consensus is strong buy with an average price target of $30.40. Rallies surfaces KZIA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for KZIA, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $8.14 |
| Market Cap | $132.17M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $17.40 |
| 52-Week Low | $2.86 |
| Volume | 151.46K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
5 analysts cover KZIA: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $30.40.